| Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells EP Mimitou, A Cheng, A Montalbano, S Hao, M Stoeckius, M Legut, ... Nature methods 16 (5), 409-412, 2019 | 433 | 2019 |
| Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis A Heczey, AN Courtney, A Montalbano, S Robinson, K Liu, M Li, ... Nature medicine 26 (11), 1686-1690, 2020 | 198 | 2020 |
| High-throughput approaches to pinpoint function within the noncoding genome A Montalbano, MC Canver, NE Sanjana Molecular cell 68 (1), 44-59, 2017 | 68 | 2017 |
| Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens N Liscovitch-Brauer, A Montalbano, J Deng, A Méndez-Mancilla, ... Nature biotechnology 39 (10), 1270-1277, 2021 | 62 | 2021 |
| Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results A Heczey, X Xu, AN Courtney, G Tian, GA Barragan, L Guo, CM Amador, ... Nature Medicine 29 (6), 1379-1388, 2023 | 52 | 2023 |
| Coding and non-coding variants in the SHOX2 gene in patients with early-onset atrial fibrillation S Hoffmann, S Clauss, IM Berger, B Weiß, A Montalbano, R Röth, ... Basic research in cardiology 111, 1-15, 2016 | 52 | 2016 |
| Retinoic acid catabolizing enzyme CYP 26C1 is a genetic modifier in SHOX deficiency A Montalbano, L Juergensen, R Roeth, B Weiss, M Fukami, S Fricke‐Otto, ... EMBO Molecular Medicine 8 (12), 1455-1469, 2016 | 25 | 2016 |
| Methods and compositions for scalable pooled rna screens with single cell chromatin accessibility profiling NE Sanjana, A Montalbano, N Liscovitch-Brauer US Patent App. 17/626,598, 2022 | 16 | 2022 |
| Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function N Jain, Z Zhao, RP Koche, C Antelope, Y Gozlan, A Montalbano, D Brocks, ... Cancer Discovery 14 (1), 142-157, 2024 | 12 | 2024 |
| Functional missense and splicing variants in the retinoic acid catabolizing enzyme CYP26C1 in idiopathic short stature A Montalbano, L Juergensen, M Fukami, CT Thiel, NH Hauer, R Roeth, ... European Journal of Human Genetics 26 (8), 1113-1120, 2018 | 12 | 2018 |
| Genome-wide CRISPR screens in spheroid culture reveal that the tumor suppressor LKB1 inhibits growth via the PIKFYVE lipid kinase JR Ferrarone, J Thomas, AM Unni, Y Zheng, MJ Nagiec, EE Gardner, ... Proceedings of the National Academy of Sciences 121 (21), e2403685121, 2024 | | 2024 |
| Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers D Steffin, N Ghatwai, A Montalbano, P Rathi, AN Courtney, AB Arnett, ... Research Square, 2024 | | 2024 |
| Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results A Heczey, X Xu, AN Courtney, G Tian, GA Barragan, L Guo, CM Amador, ... Nature medicine 30 (4), 1210, 2024 | | 2024 |
| GD2-CAR NKTS CAN INDUCE ANTITUMOR RESPONSES IN CHILDREN WITH NEUROBLASTOMA (NB) AND BTG1 REPRESSION CAN FURTHER BOOST THEIR THERAPEUTIC POTENTIAL IN NB MODELS AA Heczey, X Xu, AN Courtney, G Tian, GA Barragan, L Guo, CM Amador, ... PEDIATRIC BLOOD & CANCER 71, S8-S8, 2024 | | 2024 |
| LKB1 suppresses growth and promotes the internalization of EGFR through the PIKFYVE lipid kinase J Ferrarone, J Thomas, A Unni, Y Zheng, M Nagiec, E Gardner, ... bioRxiv, 2023.10. 19.563158, 2023 | | 2023 |
| Efficient and Specific Multi-Locus Editing of Allogeneic CAR T Cells for Hypoimmunity during Large Scale Manufacture Using Cas12b C Chaivorapol, P Beauchesne, R De Jesus, WE Dowdle, X Chen, ... Blood 140 (Supplement 1), 1606-1607, 2022 | | 2022 |
| Expanding the CITE-seq tool-kit: Detection of proteins, transcriptomes, clonotypes and CRISPR perturbations with multiplexing, in a single assay E Mimitou, A Cheng, A Montalbano, S Hao, M Stoeckius, M Legut, ... | | |
